Revenue, 2023 (US$M)
$6.2
Forecast, 2030 (US$M)
$8.0
CAGR, 2024 - 2030
3.7%
Report Coverage
UAE

UAE pancreatic cancer diagnostic market, 2018-2030 (US$M)

UAE

UAE pancreatic cancer diagnostic market highlights

  • The UAE pancreatic cancer diagnostic market generated a revenue of USD 6.2 million in 2023 and is expected to reach USD 8.0 million by 2030.
  • The UAE market is expected to grow at a CAGR of 3.7% from 2024 to 2030.
  • In terms of segment, outpatient facilities was the largest revenue generating end use in 2023.
  • Home Care is the most lucrative end use segment registering the fastest growth during the forecast period.


Pancreatic cancer diagnostic market data book summary

Market revenue in 2023USD 6.2 million
Market revenue in 2030USD 8.0 million
Growth rate3.7% (CAGR from 2023 to 2030)
Largest segmentOutpatient facilities
Fastest growing segmentHome Care
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationHospitals, Outpatient Facilities, Home Care, Research & Manufacturing
Key market players worldwideThermo Fisher Scientific Inc, Qiagen NV, Illumina Inc, Roche Holding AG ADR, BD, Agilent Technologies Inc, Myriad Genetics Inc, Koninklijke Philips NV, Abbott Laboratories, Hitachi Ltd, Danaher Corp, Prestige Medical


Other key industry trends

  • In terms of revenue, UAE accounted for 0.2% of the global pancreatic cancer diagnostic market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Middle East & Africa, Saudi Arabia pancreatic cancer diagnostic market is projected to lead the regional market in terms of revenue in 2030.
  • UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 8.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Pancreatic Cancer Diagnostic Market Companies

Name Profile # Employees HQ Website

UAE pancreatic cancer diagnostic market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pancreatic cancer diagnostic market will help companies and investors design strategic landscapes.


Outpatient facilities was the largest segment with a revenue share of 62.9% in 2023. Horizon Databook has segmented the UAE pancreatic cancer diagnostic market based on hospitals, outpatient facilities, home care, research & manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.


Several favorable strategic initiatives have been undertaken in the country. In April 2022, Viafet Genomics Laboratory collaborated with Euformatics to provide carrier screening and clinical diagnostics in the UAE. Similarly, in July 2022, G42 Healthcare expanded its clinical genetics offerings with the launch of 250 comprehensive testing panels with the shortest turnaround time.

Moreover, the UAE is one of the leading contributors to the cancer burden in the MEA. According to UAE National Cancer Registry in 2019, the country reported over 4,633 new cancer cases, of which 4,381 were malignant and 252 were in situ cases.

Hence, the high disease burden in the country is expected to fuel the demand for new cancer testing laboratories with advanced diagnostics tests. In May 2020, a new liquid biopsy laboratory was established at the Thumbay Research Institute for Precision Medicine at the Gulf Medical University. This laboratory facilitated cancer diagnosis and management in the UAE.

Reasons to subscribe to UAE pancreatic cancer diagnostic market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of UAE pancreatic cancer diagnostic market databook

  • Our clientele includes a mix of pancreatic cancer diagnostic market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the UAE pancreatic cancer diagnostic market , including forecasts for subscribers. This country databook contains high-level insights into UAE pancreatic cancer diagnostic market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

UAE pancreatic cancer diagnostic market size, by end use, 2018-2030 (US$M)

UAE Pancreatic Cancer Diagnostic Market Outlook Share, 2023 & 2030 (US$M)

UAE pancreatic cancer diagnostic market size, by end use, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more